Nuacht

Could YOU make a pile of cash investing in the never-ending craze for Mounjaro and Ozempic?
There is a bottomless appetite for news about weight-loss drugs. We cannot hear enough about the celebrities, politicians and ...
inews.co.uk on MSN11 uair an chloig
Get your NHS weight-loss jab at the pharmacy under Streeting obesity plan
The Health Secretary will set out a 10-year plan including proposals to bring down the cost of drugs such as Wegovy and ...
The Mirror US on MSN16 uair an chloig
Infertile mom 'beyond shocked' as Mounjaro jab results in miracle baby
While there is no clear evidence that GLP-1 medications can increase chances of pregnancy, there is a strong correlation ...
This Dirt Cheap Healthcare Stock Could Be a Hidden Artificial Intelligence (AI) Opportunity (Hint: It's Not Eli Lilly)
Artificial intelligence (AI) has the potential to transform several different areas of the healthcare industry.
India defies global gloom: Domestic, health demand drive long-term growth
Enter global pharmaceutical giants. US-based Eli Lilly and Novo Nordisk have both launched GLP-1-based treatments in India in ...
Notable healthcare headlines for the week: Novo Nordisk, Amgen and UnitedHealth in focus
UnitedHealth Group’s ( UNH) new CEO, Stephen Hemsley, is shaking up the senior management of the company, appointing Patrick Conway, newly named CEO of the managed care giant’s Optum unit, as the head ...